CalciMedica Statistics

Total Valuation

CalciMedica has a market cap or net worth of $43.10 million. The enterprise value is $17.39 million.

Market Cap	43.10M
Enterprise Value	17.39M

Important Dates

The last earnings date was Tuesday, August 29, 2023, after market close.

Earnings Date	Aug 29, 2023
Ex-Dividend Date	n/a

Share Statistics

CalciMedica has 10.75 million shares outstanding. The number of shares has increased by 1,120.73% in one year.

Shares Outstanding	10.75M
Shares Change (YoY)	+1,120.73%
Shares Change (QoQ)	+123.96%
Owned by Insiders (%)	14.67%
Owned by Institutions (%)	59.64%
Float	4.56M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	2.50
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.21, with zero debt.

Current Ratio	6.21
Quick Ratio	n/a
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -111.10% and return on invested capital (ROIC) is -124.67%.

Return on Equity (ROE)	-111.10%
Return on Assets (ROA)	-79.20%
Return on Capital (ROIC)	-124.67%
Revenue Per Employee	n/a
Profits Per Employee	-$1.15M
Employee Count	13
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +2.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+2.04%
50-Day Moving Average	5.22
200-Day Moving Average	4.08
Relative Strength Index (RSI)	38.69
Average Volume (20 Days)	71,137

Short Selling Information

The latest short interest is 16,976, so 0.16% of the outstanding shares have been sold short.

Short Interest	16,976
Short Previous Month	23,590
Short % of Shares Out	0.16%
Short % of Float	0.37%
Short Ratio (days to cover)	1.08

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-21.50M
Pretax Income	-14.94M
Net Income	-14.94M
EBITDA	-14.88M
EBIT	-14.94M
Earnings Per Share (EPS)	-$2.15

Full Income Statement

Balance Sheet

The company has $25.71 million in cash and no debt, giving a net cash position of $25.71 million or $2.39 per share.

Cash & Cash Equivalents	25.71M
Total Debt	n/a
Net Cash	25.71M
Net Cash Per Share	$2.39
Equity (Book Value)	17.25M
Book Value Per Share	1.60
Working Capital	22.32M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$25.09 million and capital expenditures -$78,000, giving a free cash flow of -$25.17 million.

Operating Cash Flow	-25.09M
Capital Expenditures	-78,000
Free Cash Flow	-25.17M
FCF Per Share	-$2.58

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CalciMedica does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-1,120.73%
Shareholder Yield	-1,120.73%
Earnings Yield	-34.66%
FCF Yield	-58.39%

Analyst Forecast

The average price target for CalciMedica is $18.60, which is 363.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$18.60
Price Target Difference	363.84%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Splits

The last stock split was on March 20, 2023. It was a reverse split with a ratio of 1:14.

Last Split Date	Mar 20, 2023
Split Type	Reverse
Split Ratio	1:14

Scores

Altman Z-Score	n/a
Piotroski F-Score	1